Uncategorized

Meet Olainfarm at the CPhI Worldwide 2017 in Frankfurt at Hall 9 Stand 2C78

on September 25, 2017

We are pleased to invite you to visit our stand 2C78 at Hall 9 at the CPhI Worldwide 2017 in Frankfurt, between 24th&26th October 2017.

Olainfarm will be on site showcasing our portfolio of FDFs, APIs and intermediates. We offer complete contract manufacturing services including research, scale-up, pilot and commercial manufacturing, as well as support with QC and validation. Our top level management will be available to discuss business with you straight away. If you are interested in setting up a meeting, please contact us stating your topic of interest, and we will reserve a timeslot for you at your preferred day and time.

Olainfarm is the leading manufacturer in the chemical and pharmaceutical sector of the Baltic States with 45 years of experience and export to more than 50 countries worldwide. Our key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. We have a long-standing technological and know-how advantage in adamantane chemistry, quinuclidine chemistry, nitrofurane chemistry and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

If you require any assistance or further information, please feel free to contact us.

 

Kind regards,
Sigita Zviedre
Head of PR
Mobile: +371 26377286
E-mail: szviedre@olainfarm.lv

read more
SigitaMeet Olainfarm at the CPhI Worldwide 2017 in Frankfurt at Hall 9 Stand 2C78

Recording of the Second Quarter 2017 Investor Conference Webinar

on September 13, 2017

On September 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of second quarter 2017 and informed about the other recent activities within the company.

The recorded JSC Olainfarm webinar is available online: ej.uz/OLF_Q22017_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: ej.uz/OLF_Q22017_EN.
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm Member of the Management
Board Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Eva DombrovskaRecording of the Second Quarter 2017 Investor Conference Webinar

Olainfarm acquires the out-patient establishment Olaines veselības centrs

on June 21, 2017

JSC Olainfarm on 21 June 2017 was registered in the Registry of Enterprises of the Republic of Latvia as the sole proprietor of Olaines veselības centrs Ltd.. The company acquired the capital shares of Olaines veselības centrs Ltd. in an auction with the winning bid of EUR 650,000. There were two bidders, and the starting price of the auction was EUR 190,000.

Following the change of owners, the business development director Viktorija Zefīrova-Tačinska was assigned as the chairperson of the Board of Olaines veselības centrs Ltd., whereas the former chairperson of the Board Jānis Klievēns will from now on perform the duties of a board member and the director of medicine.

The chair of the Olaine Municipal Council A. Bergs is certain that: “The new owner of the company, by investing in it, will develop health care in the municipality and will ensure a greater range and better quality of medical services to the residents.”

“We are planning to expand the range of services of Olaines veselības centrs with cardiology, sonography and rehabilitation services, as well as renew the equipment and attract new specialists. The development plans also include the establishment of a day in-patient clinic and a modern health recovery centre. By consolidating co-operation with the local government and organisations under its wing, we will be taking part in events promoting a healthy lifestyle,” explains Viktorija Zefīrova-Tačinska, the chairwoman of the Board of Olaines veselības centrs Ltd. and the business development director of  JSC Olainfarm.

Olaines veselības centrs Ltd. employs 44 people. Olaines veselības centrs Ltd. ensures out-patient health care services, as well as diagnostic testing. Additionally, day in-patient and laboratory services are provided. The company’s turnover in 2016 reached EUR 492,656 with EUR 4016 in profits.

Olainfarm group of companies consist of the parent company JSC Olainfarm, phartmacy chain of Latvijas aptieka Ltd., producer of eco-cosmetics Kiwi Cosmetics Ltd., producer of elastic and compression materials products Tonus Elast Ltd., medical company Klīnika Diamed Ltd. and the Belarussian producer of herbal teas and medicinal herb powders NPK Biotest Ltd.. JSC Olainfarm also owns 96.69% of capital shares of the largest Latvian food supplement producer Silvanols Ltd..

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Further information:
Sigita Zviedre
Head of PR
Mobile: +371 26377286
E-mail: slapsina@olainfarm.lv

read more
SigitaOlainfarm acquires the out-patient establishment Olaines veselības centrs

Sales of Olainfarm in May Increase by 19%

on June 15, 2017

Preliminary consolidated results of JSC Olainfarm for May 2017 show that the sales of the company during this period have reached 10.81 million, which represents an increase by 19% compared to the same period of last year. The biggest sales increase has been achieved in The Netherlands, where sales grew by 4214%. Sales to Kazakhstan increased by 316%, sales to Tajikistan increased by 162% and sales to Belarus increased by 136%. During May of 2017, JSC Olainfarm also made significant shipments to Germany. The biggest sales markets of JSC Olainfarm in May were Russia, Latvia, Ukraine, Belarus and The Netherlands.

May 2017, consolidated sales Sales, Thsnd. EUR Changes to May, 2016 Share in total sales
Russia 3 389 -11% 31%
Latvia 2 335 35% 22%
Ukraine 1 134 13% 10%
Belarus 879 136% 8%
The Netherlands 839 4214% 8%
Tajikistan 364 162% 3%
Uzbekistan 302 13% 3%
Kazakhstan 284 316% 3%
Germany 157 NA 1%
Lithuania 169 42% 2%
Other 961 -38% 9%
Total 10 813 19% 100%

 

Sales of Latvijas aptieka Ltd. during May 2017 were 1.7 million euros, which represents an increase by 31% compared to the same period of 2016. Sixty-five pharmacies were operating during this period. Sales of Silvanols Ltd. in May 2017 reached 0.38 million, which is an increase by 12% compared to May of 2016. During May 2017, Silvanols Ltd. sold its products to eight European countries during this period and with assistance of JSC Olainfarm also to Kazakhstan, Lithuania, Russia and Armenia. Sales of Tonus Elast Ltd. during May 2017 reached 0.55 million euros. The company made its sales in 22 countries in four continents

According to preliminary results, consolidated sales of JSC Olainfarm in five months reached 49.01 million euros, which represents an increase by 11% compared to five months of 2016. The biggest sales increase was achieved in The Netherlands, where sales grew by 561%, and Germany, where sales grew by 230%. Biggest sales reductions took place in Ukraine, where sales shrunk by 40% and Turkmenistan, where sales shrunk by 36%. Major sales markets of the group during May 2017 were Russia, Latvia, Belarus, Ukraine and The Netherlands.

5 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 5 months of 2016 Share in total sales
Russia 15 753 20% 32%
Latvia 12 188 16% 25%
Belarus 4 572 12% 9%
Ukraine 4 344 -40% 9%
The Netherlands 3 331 561% 7%
Kazakhstan 988 34% 2%
Italy 825 40% 2%
Lithuania 700 23% 1%
Germany 654 230% 1%
Turkmenistan 590 -36% 1%
Other 5 068 -12% 10%
Total 49 014 11% 100%

 

Sales of Latvijas aptieka Ltd. in five months of 2017 were 8.5 million euros, which represents an increase by 8% compared to the same period of 2016. Sales of Silvanols Ltd. during this period were 2.45 million euro, which represents an increase by 23% compared to five months of 2016. Products of Silvanols Ltd. were sold to nine European countries and, with the help of JSC Olainfarm also to Lithuania, Russia, Azerbaijan, Belarus and Armenia. Sales of Tonus Elast Ltd. in five months reached 3.1 million euros, and its products were sold to 33 countries in four continents.

According to unconsolidated preliminary results for May 2017, sales of JSC Olainfarm during this period reached 9.09 million euros, which represents an increase by 9% compared to the same period of 2016. The biggest sales increase was achieved in The Netherlands, where sales grew by 4214%. Sales to Kazakhstan grew by 243%, sales to Tajikistan increased by 150%, but sales to Belarus grew by 136%. Significant shipments were also made to Germany. The major sales markets during this period were Russia, Latvia, Ukraine, Belarus and The Netherlands. During May 2017, products of JSC Olainfarm were sold to 28 countries in three continents.

May 2017, unconsolidated sales Sales, thsnd. EUR Changes to May, 2016 Share in total sales
Russia 3 234 -15% 36%
Latvia 1 171 8% 13%
Ukraine 1 134 13% 12%
Belarus 879 136% 10%
The Netherlands 839 4214% 9%
Tajikistan 347 150% 4%
Uzbekistan 302 13% 3%
Kazakhstan 235 243% 3%
Germany 154 NA 2%
Lithuania 146 43% 2%
Other 649 -56% 7%
Total 9 090 9% 100%

 

According to preliminary unconsolidated numbers, sales of JSC Olainfarm in five months of 2017 reached 39.75 million euros, which represents an increase by 3% compared to the same period of 2016. The most rapid sales increase was achieved in The Netherlands, where sales grew by 561% and Germany, where sales grew by 226%. The biggest sales reduction during this time took place in Ukraine, where sales shrunk by 41%. The major sales markets of JSC Olainfarm during these five months were Russia, Latvia, Belarus, Ukraine and The Netherlands. In total during five months of 2017, products of JSC Olainfarm were sold to 40 countries in five continents.

Five months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to five months of 2016 Share in total sales
Russia 14 436 10% 36%
Latvia 6 034 5% 15%
Belarus 4 521 11% 11%
Ukraine 4 252 -41% 11%
The Netherlands 3 331 561% 8%
Italy 792 35% 2%
Kazakhstan 699 -5% 2%
Germany 646 226% 2%
Turkmenistan 590 -36% 1%
Lithuania 580 19% 1%
Other 3 867 -26% 10%
Total 39 748 3% 100%

 

General meeting of shareholders of JSC Olainfarm held on June1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in five months of 2017 the company has met 41% of annual target for unconsolidated sales and 39% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

 

read more
SigitaSales of Olainfarm in May Increase by 19%

About resignation of Jelena Borcova, Member of the Board

on May 18, 2017

JSC Olainfarm hereby informs that on May 17, 2017 it has received a letter of resignation from its Board member Mrs. Jelena Borcova, whereby she resigns from the position of the Board member by May 18, 2017.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaAbout resignation of Jelena Borcova, Member of the Board

Curriculum Vitae of Andis Krumins, Candidate for Council Membership of JSC Olainfarm

on May 17, 2017

EDUCATION:

2014-2017 Psychiatry studies at post-graduate Program of Riga Stradins University

1990-1997 Doctoral studies at Medical Faculty of Latvian Medical Academy

 

PROFESSIONAL EXPERIENCE:

2017

Psychiatry and Narcology Center of Riga

Residing doctor

SIA “AO Solutions”

Member of the Board

Latvian Foundation for Development of Radiology

Member of the Board

 

2004 – 2014

SIA “Multitrial Clinical Trials”

Member of the Board

 

2003

Latvian Ministry of Health

Parliamentary Secretary

 

Number of shares of AS Olainfarm owned: 0

 

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
SigitaCurriculum Vitae of Andis Krumins, Candidate for Council Membership of JSC Olainfarm

Announcement of inclusion of additional item into Agenda of Annual shareholders meeting of JSC Olainfarm to be held on 01.06.2017.

on May 15, 2017

Joint Stock Company Olainfarm (reg. No. 40003007246, legal address: Rupnicu street 5, Olaine, LV-2114) the Management Board hereby announces that the following item has been additionally included into the agenda of the Annual shareholders meeting scheduled for June 01st, 2017:

  • Election of the Council.

Additional item has been included into agenda due to receipt of the May 12th, 2017, resignation notice by the Council member Geliia Gildeeva based on the rights provided by part 8 article 296 of the Commercial law of the Republic of Latvia.

 

JSC Olainfarm Management Board

 

 

Information prepared by:

Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaAnnouncement of inclusion of additional item into Agenda of Annual shareholders meeting of JSC Olainfarm to be held on 01.06.2017.

Report of the Supervisory Council of JSC Olainfarm to the General Meeting of Shareholders

on May 2, 2017

Supervisory Council of JSC Olainfarm has read the Consolidated and Parent Company’s Annual reports for 2016, as well as Independent Auditors’ Report about it. In addition, the Council has assessed financial position of the Company and Operations of the Management Board during this financial year and hence produced this Report.

The Council values the work conducted by Company’s Board during the last year as satisfactory, because, although its operations allowed the Company to significantly increase its sales in 2016, due to several unfavorable decisions and conditions it had to make significant provisions during this period, resulting in considerable profit reduction. The Council highly appreciated the acquisition of Tonus Elast Ltd., which is so far the biggest acquired daughter company of the Group. Tonus Elast Ltd. is the company with a very strong and clearly not fully realized export potential. The Council urges the Board to closely follow that during the harmonization of processes positions of Tonus Elast Ltd. in its existing markets are not harmed. With regard to other acquisitions of 2016 and the upcoming ones, the Council asks the Board to assess financial feasibility of such, especially if the target operates in a sector where expertise of the Company itself is very limited. The Council supports an opinion that for more rapid growth the Company must rather focus on acquisition of a larger company with greater development potential, than waste its financial and other resources on smaller, riskier and administratively more demanding objects.

Rapid decline in Company’s profitability and significant provisions for doubtful receivables made in 2016 makes the Council to draw Board’s attention to issues directly related to Company’s profitability, specifically, to necessity to more carefully assess the recoverability of assets and justification and transparency of marketing and sales costs of Parent Company and daughter companies. The Council fully appreciates that when entering new markets or launching new products bigger sales and marketing costs are unavoidable. However, the Council asks the Board to be more critical regarding the necessity to bear significant marketing costs for well-established products in well-established countries.

During 2016 the Council continued following the development of different companies in the Group. And this is the second year in a row, when the Council wants to specifically emphasize rapid and positive development of Silvanols Ltd.. 2016 has been the second year in a row when this company makes significant profit from its main operations. It is particularly satisfying that 2016 is going to be the first year, when this company pays dividends to its shareholders from its profits gained that year.

The Council is satisfied that the Board is dedicated to solve the related party lending issue and is suggesting the relatively high dividend payments of 0.64 cents per share, making the payments in three installments at the end of second, third and fourth quarters. The Council shares Boards conservatism in approach to Company’s liquidity this year, but would like to draw the attention of the Board and shareholders that therefore suggests to abstain from it.

During 2016 the Council of the Company has performed its duties and supervised operations of the Company according to legislation, decisions by the general meeting. The Council has approved financial statements and overviewed operations of Company’s management. During the reporting period 17 Council meetings were held. During these meetings, Board reports, Board composition, plans, planned and actual budgets were reviewed. Agenda items of general meeting was pre-approved. Council found no significant insufficiencies in Boards operations in 2016. The Board has been in constant consultations with the Council and has taken into account all previously mentioned and other recommendations of the Council targeted at safe further development of the Company.

The Council would like to take this opportunity to thank the Board, all employees of the Company and its partners for cooperation in 2016, and to wish successful, stable and positively challenging next year.

 

Approved by the Council Meeting on April 28, 2017

Chairman of the Council                    Ivars Godmanis

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaReport of the Supervisory Council of JSC Olainfarm to the General Meeting of Shareholders

Announcement About Convening of the Annual General Meeting of Olainfarm

on May 2, 2017

Management Board of the Joint Stock company Olainfarm (registration number. 40003007246, registered  address: Rupnicu iela 5, Olaine, LV-2114) convenes and announces that the Annual General Meeting of JSC Olainfarm Shareholders will be held on June 01st, 2017 at 11:00 at the  premises of JSC Olainfarm in Olaine, Rupnicu iela 5.

Agenda:

  1. Report of the Management Board about the results of operations in 2016.
  2. Report of the Council about the results of operations in 2016.
  3. Report of the Auditing Committee about 2016.
  4. Approval of JSC Olainfarm Сonsolidated and Parent Сompany’s Annual Report for year 2016.
  5. Distribution of reserves.
  6. Distribution of profit of 2016.
  7. Report of the Management Board about the budget and operational plan for 2017.
  8. Amendment of Statutes.
  9. Elections of the sworn auditor for 2017 and setting of the remuneration for the sworn auditor.
  10. Elections of the Auditing Committee and setting of the remuneration of the Auditing  Committee.

Registration of the shareholders will take place on the day of the meeting, i.e. June 01st, 2017 from  10:00 until 10:45 on the venue.

Total number of shares and the total number of the voting shares of JSC Olainfarm is 14 085 078.

Date of the record for participation of the shareholders in the Annual General Meeting of shareholders  of JSC Olainfarm is May 24th, 2017. Only those who are the shareholders at the date of record have  the right to participate in the Annual General Meeting of shareholders on June 01st, 2017, with the  number of shares held by them at the date of record.

Shareholders may participate in the Annual General Meeting of shareholders either in person or  represented through a proxy:

– When registering the shareholders must present either the passport or other  identification document;

– When registering the representatives of the shareholders must present the passport or  other identification document, submit a written power of attorney by the represented shareholder (the  form of the power of attorney is available at JSC Olainfarm web-site  http://www.olainfarm.lv, web-site of the system of Central Storage of Regulated Information http://www.oricgs.lv; and web-site   of JSC  NASDAQ OMX Riga http://www.nasdaqbaltic.com) or the legal representative has to present a document confirming the authority.

Shareholders have the following rights:

– shareholders that represent at least 1/20 of the capital of the company have the right  to within 7 days after the announcement is published to request the Management Board of JSC Olainfarm  to include additional items in the agenda. Shareholders that request inclusion of additional items in  the agenda of the Annual General Meeting of shareholders must submit to the Management Board of JSC  Olainfarm draft decisions about the issues to be included in the agenda upon their request or  explanations about the item, if no decision is planned;

– within 7 days after the publishing of this announcement, submit draft decisions about  the items of agenda.  Should all submitted draft decisions be reviewed and declined, shareholders may  submit their proposed draft decisions during the Annual General Meeting of Shareholders itself;

– should the shareholder submit an inquiry at least 7 days before the Annual General  Meeting of shareholders, the Management Board shall at least 3 days before the Annual General Meeting  of shareholders provide the requested information about the items included in the agenda. It is a duty  of the Management Board to upon the request of the shareholder provide information about the economic  situation of the company to the extent necessary for objective decision-making of the particular item  on the agenda.

Shareholders may see the draft resolutions of the Annual general Meeting of Shareholders from May 18,  2017 until May 31, 2017 on business days from 09:00 until 16:00 in Olaine, Rupnicu iela 5, in the Legal  division of JSC Olainfarm, if scheduled in advance through telephone + 371 6 7013 870 or on the web  page of JSC Olainfarm  http://www.olainfarm.lv, but on the day of the Annual General Meeting – at the registration desk.

JSC Olainfarm Сonsolidated and Parent Сompany’s Annual Report for year 2016, report of the independent auditors, report of the Council, Corporate governance report, profit distribution proposals and Statute amendments are available at web page of JSC „Olainfarm”  http://www.olainfarm.lv, web-page of the system of Central Storage of Regulated Information http://www.oricgs.lv and the web page of JSC NASDAQ OMX Riga http://www.nasdaqbaltic.com.

Management Board of Joint Stock Company Olainfarm

 

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
SigitaAnnouncement About Convening of the Annual General Meeting of Olainfarm